mechan
human
immunodefici
viru
type
cross
mucos
surfac
establish
infect
unknown
acid
genit
secret
women
contain
like
coat
antibodi
found
combin
acid
ph
envspecif
igg
includ
cervicovagin
semin
fluid
individu
augment
transcytosi
across
epitheli
cell
much
compar
envspecif
igg
neutral
ph
nonspecif
igg
either
ph
enhanc
transcytosi
observ
clinic
isol
includ
transmit
founder
strain
elimin
fc
neonat
receptor
fcrn
knockdown
epitheli
cell
nonneutr
antibodi
allow
similar
less
transcytosi
neutral
antibodi
howev
ratio
total
infecti
viru
higher
neutral
antibodi
indic
allow
transcytosi
block
infect
transcytos
viru
immunocytochemistri
reveal
abund
fcrn
express
columnar
epithelia
line
human
endocervix
penil
urethra
acid
envspecif
igg
enhanc
transcytosi
viru
across
epitheli
cell
via
fcrn
could
facilit
transloc
viru
suscept
target
cell
follow
sexual
exposur
sexual
transmiss
requir
viru
establish
infect
across
genit
tract
intestin
tissu
sexual
transmit
infect
caus
inflamm
local
trauma
may
allow
suscept
target
cell
skin
mucos
surfac
becom
directli
expos
secret
infect
sexual
partner
howev
skin
mucosa
intact
remain
unclear
precis
gain
access
target
cell
one
possibl
viru
transloc
epitheli
cell
suscept
cell
found
either
epithelium
altern
langerhan
cell
may
sampl
surfac
acquir
viru
move
area
abund
target
cell
final
transcytosi
ie
movement
cell
studi
potenti
mechan
transloc
viru
mucos
surfac
deeperli
cell
transcytosi
offer
explan
movement
viru
across
epitheli
cell
form
tight
junction
might
normal
exclud
pathogen
move
beyond
surfac
howev
vitro
small
amount
viru
usual
less
cellfre
viru
inoculum
find
way
cell
medium
bath
basolater
surfac
interact
env
sever
host
cell
surfac
molecul
includ
glycolipid
heparan
sulfat
proteoglycan
propos
play
role
transcytosi
except
acut
phase
prior
develop
immun
respons
semen
cervicovagin
rectal
fluid
individu
contain
antibodi
env
concentr
envspecif
igg
present
secret
vari
consider
person
person
usual
order
less
concentr
found
plasma
presenc
envspecif
igg
strongli
suggest
proport
env
molecul
surfac
infecti
virion
genit
tract
secret
coat
igg
sinc
success
transmit
sexual
coat
antibodi
either
insuffici
quantiti
qualiti
neutral
viru
infect
upon
contact
uninfect
partner
antibodi
genit
tract
secret
individu
could
play
role
facilit
transport
viru
across
mucos
epithelia
role
made
particularli
plausibl
report
express
fc
neonat
receptor
fcrn
human
genit
mucos
tissu
fcrn
heterodimer
receptor
belong
mhc
class
famili
protein
express
fcrn
endotheli
cell
thought
critic
igg
homeostasi
blood
express
placent
syncytiotrophoblast
key
factor
transport
matern
igg
fetal
circul
characterist
fcrn
abil
bind
fc
region
igg
acid
ph
releas
neutral
ph
phdepend
bind
allow
transport
intact
igg
igg
immun
complex
lumin
surfac
bath
acid
fluid
exampl
cervicovagin
secret
basolater
surfac
expos
neutral
intracellular
milieu
cervicovagin
secret
maintain
acid
ph
acidproduc
bacteria
make
part
normal
vagin
microbiota
although
perturb
normal
microbiota
occur
bacteri
vaginosi
rais
ph
secret
gener
remain
acid
rang
semen
rapidli
neutral
cervicovagin
secret
extent
ph
chang
variabl
exampl
larg
amount
ejacul
may
rais
ph
neutral
rang
wherea
small
amount
may
ph
rectal
secret
rang
given
genit
tract
secret
may
complex
igg
antibodi
femal
genit
tract
secret
acid
fcrn
demonstr
genit
tract
tissu
evalu
role
ph
antibodi
transcytosi
polar
epitheli
cell
acid
ph
envspecif
igg
enhanc
transcytosi
investig
effect
low
ph
antibodi
transcytosi
across
epitheli
cell
form
tight
junction
expos
apic
surfac
cell
ph
without
igg
hivig
viru
quantifi
medium
bath
basolater
cell
surfac
subnat
fluid
rtpcr
although
detect
earli
six
hour
exposur
viru
apic
cell
surfac
quantiti
greater
hour
figur
thu
subsequ
experi
transcytosi
measur
hour
use
clade
b
clinic
isol
hivig
enhanc
transcytosi
dosedepend
manner
viru
antibodi
expos
apic
surfac
ph
figur
increas
transcytosi
hivig
ph
hivneg
igg
ivig
ph
found
similarli
enhanc
transcytosi
use
addit
well
strain
figur
importantli
transcytosi
four
five
clade
c
transmittedfound
envpseudotyp
virus
enhanc
ph
antibodydepend
manner
figur
enhanc
transcytosi
antibodi
low
ph
also
occur
colon
carcinoma
cell
figur
sinc
sexual
transmiss
may
occur
small
amount
viru
investig
phand
antibodydepend
enhanc
transcytosi
could
occur
low
inocula
use
hivig
monoclon
antibodi
mab
found
transcytosi
occur
viru
inocula
low
pg
rna
copi
hivig
pg
rna
copi
amount
small
detect
subnat
fluid
absenc
low
ph
antibodi
tabl
quantiti
viru
within
rang
observ
semin
cervicovagin
fluid
hivinfect
individu
impact
antibodi
low
ph
suggest
fcrn
involv
knock
fcrn
cell
verifi
lower
express
flow
cytometri
western
blot
figur
knockdown
cell
attain
level
electr
resist
wildtyp
cell
data
shown
indic
fcrn
knockdown
affect
abil
form
tight
junction
unlik
wildtyp
cell
enhanc
transcytosi
fcrnknockdown
cell
either
mab
figur
polyclon
hivig
data
shown
use
also
evalu
fc
mutant
envspecif
mab
mutant
design
abrog
fcrn
bind
markedli
lower
transcytosi
compar
wildtyp
figur
second
mutant
design
bind
higher
affin
fcrn
increas
transcytosi
compar
wildtyp
figur
bind
jrfl
figur
neutral
jrfl
figur
nearli
equival
wildtyp
fc
mutant
version
indic
fc
mutat
affect
fabantigen
bind
blockad
fcrn
caus
sexual
transmit
diseas
howev
mechan
employ
viru
cross
genit
tract
tissu
establish
infect
uncertain
sinc
cervicovagin
fluid
acid
cervicovagin
fluid
like
coat
antibodi
explor
effect
low
ph
antibodi
transcytosi
movement
across
tightjunct
epitheli
cell
found
combin
antibodi
low
ph
enhanc
transcytosi
much
viru
underw
transcytosi
condit
infecti
infect
highli
influenc
whether
antibodi
neutral
viru
observ
enhanc
transcytosi
use
antibodi
cervicovagin
semin
fluid
use
transmit
founder
strain
also
found
enhanc
transcytosi
due
fc
neonat
receptor
fcrn
bind
immun
complex
acid
ph
releas
neutral
ph
final
stain
human
tissu
reveal
abund
fcrn
express
columnar
epitheli
cell
penil
urethra
endocervix
find
reveal
novel
mechan
wherein
may
facilit
transmiss
usurp
antibodi
respons
direct
result
import
implic
hiv
vaccin
develop
understand
earliest
event
hiv
transmiss
antifcrn
antibodi
inhibit
endosom
acidif
bafilomycin
also
substanti
reduc
elimin
enhanc
transcytosi
figur
f
competit
mab
env
mab
figur
consist
investig
fcfcrn
interact
maxim
enhanc
transcytosi
occur
ph
enhanc
transcytosi
appar
ph
figur
sinc
fcrn
bind
igg
iga
compar
two
differ
mab
iga
classswitch
version
mab
enhanc
transcytosi
jrfl
pseudovirus
shiv
ph
wherea
iga
classswitch
version
figur
fact
report
dimer
inhibit
transcytosi
thu
enhanc
transcytosi
low
ph
presenc
specif
antibodi
mediat
igg
depend
fcrn
use
mgml
transcytosi
igg
alon
increas
approxim
fold
ph
ph
figur
howev
effect
fcrnmediat
transcytosi
igg
alon
appear
strong
effect
igg
immun
complex
exampl
complex
made
mgml
increas
transcytosi
condit
allow
fcrn
engag
differ
may
due
contribut
fluid
phase
uptak
igg
epitheli
cell
ph
ph
igg
thu
intern
engag
fcrn
acid
endosom
shuttl
basolater
side
cell
intern
immun
complex
hand
like
depend
primarili
fcrn
engag
surfac
cell
ph
evalu
abil
hivig
panel
mab
variabl
neutral
activ
mediat
phdepend
transcytosi
fulli
infecti
jrfl
inhibitori
concentr
ic
antibodi
rang
mgml
fig
poorli
neutral
antibodi
hivig
mab
figur
neutral
mab
figur
enhanc
transcytosi
ph
mgml
transcytosi
correl
directli
mab
bind
jrfl
spearman
rho
p
invers
ic
mab
spearman
rho
p
figur
ph
envspecif
mab
hivig
mediat
transcytosi
viru
infect
tzmbl
cell
figur
howev
strong
correl
amount
transcytos
infecti
viru
neutral
activ
ic
antibodi
mediat
transcytosi
spearman
rho
p
viru
whose
transcytosi
mediat
poorli
neutral
antibodi
hivig
least
concentr
mgml
infecti
viru
cross
epitheli
cell
nonfcrndepend
manner
ie
presenc
control
mab
fig
convers
transcytosi
mediat
antibodi
lowest
ic
result
less
infecti
viru
observ
control
antibodi
figur
thu
strong
bind
activ
result
fcrndepend
transcytosi
wherea
strong
neutral
activ
render
transcytos
viru
less
infecti
point
illustr
ratio
percenttranscytos
percentinfecti
viru
figur
exampl
everi
infecti
unit
time
viru
transcytos
hivig
figur
note
independ
transcytosi
jrlf
infect
tzmbl
cell
increas
incub
viru
hour
ph
compar
ph
howev
ic
similar
differ
two
ph
valu
ph
comparison
done
data
shown
viru
infect
essenti
abrog
incub
ph
data
shown
igg
genit
tract
secret
enhanc
transcytosi
ph
next
determin
whether
igg
purifi
cervicovagin
fluid
semin
fluid
could
enhanc
transcytosi
low
ph
use
igg
cervicovagin
fluid
three
hivinfect
women
semin
fluid
three
infect
men
enhanc
transcytosi
occur
igg
concentr
well
within
expect
rang
genit
tract
secret
figur
abil
genit
tract
igg
mediat
transcytosi
correl
strongli
infecti
viru
captur
activ
igg
spearman
rho
p
figur
less
bind
monomer
env
glycoprotein
viru
strain
rho
p
figur
none
genit
tract
igg
abl
neutral
hiv
clinic
strain
use
experi
igg
concentr
high
mg
ml
shown
consist
hivig
nonneutr
mab
higher
concentr
genit
tract
igg
gener
result
greater
infect
transcytos
viru
figur
fcrn
express
previous
report
human
uterin
vagin
epitheli
cell
use
immunohistochemistri
survey
fcrn
protein
express
variou
site
human
genit
tract
detect
abund
fcrn
express
columnar
epitheli
cell
line
human
penil
urethra
figur
figur
endocervix
figur
figur
contrast
littl
fcrn
protein
observ
vaginalectocerv
squamou
epithelia
express
occur
basal
epitheli
layer
figur
figur
similar
stain
pattern
observ
foreskin
tissu
data
shown
femal
genit
tract
secret
often
acid
secret
hivinfect
individu
antibodi
capabl
coat
viru
contain
secret
fact
led
us
explor
role
antibodi
low
ph
transcytosi
across
epitheli
cell
primari
find
acid
ph
igg
enhanc
transcytosi
clinic
isol
includ
transmittedfound
envpseudotyp
strain
moreov
antibodi
cervicovagin
semin
fluid
mediat
enhanc
transcytosi
low
ph
enhanc
transcytosi
abrog
block
knock
fcrn
known
bind
igg
immun
complex
low
ph
releas
neutral
ph
also
establish
viru
transloc
across
epitheli
cell
incub
antibodi
low
ph
remain
infecti
although
neutral
antibodi
gener
promot
transcytosi
transcytos
viru
rel
less
infecti
viru
whose
transcytosi
mediat
nonneutr
antibodi
final
demonstr
abund
fcrn
protein
express
columnar
epitheli
cell
human
endocervix
penil
urethra
suggest
site
could
play
major
role
fcrnmediat
immun
complex
transcytosi
result
indic
fcrn
may
respons
shuttl
iggbound
across
epitheli
cell
genit
tract
consist
studi
highlight
role
fcrn
immun
complex
shuttl
across
tissu
mice
express
human
fcrn
intestin
epitheli
cell
abl
deliv
igg
lumin
intestin
surfac
could
bind
cognat
antigen
return
immun
complex
back
lamina
propria
present
dendrit
cell
cell
addit
cytomegaloviru
cmv
appli
human
placent
explant
women
high
anticmv
neutral
antibodi
activ
rapidli
transcytos
across
syncytiotrophoblast
captur
villu
macrophag
condit
viru
replic
howev
explant
cmvseroposit
women
low
undetect
neutral
antibodi
viru
replic
readili
occur
cytotrophoblast
underli
intact
uninfect
syncytiotrophoblast
layer
thu
appear
neutral
antibodi
inhibit
infect
allow
viru
cross
syncytiotrophoblast
layer
hand
nonneutr
antibodi
allow
even
promot
infect
syncytiotrophoblast
express
high
level
fcrn
fcrn
explant
block
iggvirion
complex
transport
across
surfac
found
fcrnmediat
transcytosi
cmv
occur
neutral
poorli
neutral
antibodi
transcytos
viru
remain
infecti
complex
poorli
neutral
antibodi
final
immunohistochem
stain
placenta
utero
infect
consist
model
fcrnmediat
transcytosi
knowledg
first
studi
investig
transcytosi
use
viru
coat
hivspecif
antibodi
acid
environ
mimic
femal
genit
tract
vitro
observ
applic
maletofemal
transmiss
via
vagin
intercours
enhanc
transcytosi
could
facilit
infect
regard
li
et
al
report
fcrn
express
bidirect
igg
transport
human
vagin
tissu
model
although
detect
fcrn
apic
layer
vagin
epithelium
detect
abund
fcrn
express
columnar
endocerv
epitheli
cell
cell
may
expos
acid
vagin
secret
occur
cervic
os
furthermor
cervic
ectopi
common
condit
character
extens
endocerv
columnar
epithelium
ectocervix
upper
vagina
implic
risk
factor
infect
preval
reproductiveag
women
cervic
lesion
expos
vagin
ph
condit
could
provid
portal
fcrnmediat
maletofemal
transmiss
fcrn
also
found
though
consist
basal
epitheli
cell
vagina
cell
lie
deep
epithelium
unlik
come
contact
acid
secret
immun
complex
unless
trauma
substanti
thin
overli
squamou
epithelium
import
note
semin
fluid
rapidli
rais
ph
cervicovagin
secret
level
would
support
immun
complexfcrn
bind
howev
ph
cervicovagin
fluid
follow
ejacul
depend
quantiti
ejacul
may
stay
within
acid
rang
furthermor
hiv
present
preejacul
secret
could
introduc
femal
genit
tract
prior
ejacul
respect
femaletomal
transmiss
peni
come
contact
vagin
secret
would
remain
acid
ph
least
ejacul
allow
time
exposur
penil
tissu
includ
foreskin
urethra
iggcoat
viru
low
ph
demonstr
abund
fcrn
human
penil
urethr
epithelium
support
model
exposur
antibodybound
might
lead
enhanc
femaletomal
transmiss
note
ph
vagin
secret
typic
ph
requir
fcfcrn
bind
howev
substanti
variabl
normal
vagin
ph
begin
observ
enhanc
transcytosi
ph
figur
furthermor
possibl
buffer
effect
foreskin
urethr
secret
foreskin
whose
presenc
increas
hiv
infect
rate
could
trap
secret
contain
immun
complex
therebi
allow
greater
urethr
exposur
infect
materi
within
ph
rang
fcfcrn
bind
addit
bacteri
vaginosi
condit
associ
increas
risk
femaletomal
well
malefemal
hiv
transmiss
result
vagin
secret
ideal
fcfcrn
bind
exposur
penil
tissu
ph
rang
fcfcrn
bind
may
also
occur
ejacul
sinc
complet
neutral
vagin
acid
may
occur
immedi
also
possibl
though
less
like
fcrn
mediat
hiv
transmiss
via
peni
insert
anal
intercours
peni
may
come
contact
slightli
acid
rectal
secret
find
igg
cervicovagin
semin
fluid
obtain
hivinfect
individu
mediat
enhanc
transcytosi
infecti
viru
suggest
biolog
relev
result
cervicovagin
semin
fluid
report
contain
averag
mgml
mg
ml
envspecif
igg
four
six
sampl
evalu
bound
infecti
mgml
moreov
sampl
mediat
transcytosi
mgml
total
igg
well
total
igg
concentr
found
genit
secret
hivinfect
men
women
even
acut
hiv
infect
risk
transmiss
uninfect
partner
highest
subject
report
igg
antibodi
igg
antibodi
cervicovagin
semin
fluid
igg
level
averag
higher
iga
level
igm
found
less
frequent
lower
quantiti
thu
immun
complex
like
occur
mucos
secret
like
contain
predominantli
igg
acid
condit
would
subject
fcrnmediat
transcytosi
expos
host
relev
find
also
support
demonstr
transcytosi
transmittedfound
strain
env
pseudotyp
viru
enhanc
antibodi
current
evalu
whether
transmittedfound
strain
comparison
chronic
strain
preferenti
transcytos
would
consist
report
show
higher
sensit
clade
b
transmittedfound
strain
antienv
antibodi
bind
find
repres
new
model
antibodydepend
enhanc
ade
infect
previou
studi
demonstr
ade
vitro
due
fccror
complementmedi
mechan
modul
interact
demonstr
enhanc
vitro
occur
level
transcytosi
across
epitheli
cell
involv
fcrn
vivo
ig
isotyp
well
neutral
activ
like
play
determin
role
whether
antibodi
might
protect
enhanc
infect
demonstr
recent
intrarect
appli
mab
less
version
prevent
shiv
infect
follow
intrarect
challeng
vitro
inhibit
transcytosi
wherea
show
version
enhanc
transcytosi
ph
anoth
studi
show
compar
irrelevantand
noantibodi
control
increas
number
transmittedfound
shiv
variant
vagin
challeng
follow
system
local
infus
nonneutr
mab
clearli
studi
found
igg
neutral
activ
prevent
lentiviru
infect
vagin
challeng
thu
wherea
strong
vaccineinduc
neutral
igg
respons
may
protect
nonneutr
igg
wane
titer
neutral
igg
present
acid
lumen
might
enhanc
transcytosi
across
mucos
barrier
allow
infect
suscept
target
cell
howev
whether
antibodi
protect
enhanc
effect
like
depend
potenc
breadth
antivir
activ
viral
strain
inflammatori
state
expos
individu
genet
factorssuch
fccr
polymorphismsthat
might
influenc
antibodi
function
final
fcrnmediat
transcytosi
appli
vivo
result
would
strengthen
argument
mucos
iga
respons
vaccinationthough
exclus
strong
igg
neutral
antivir
responsesinc
iga
inhibit
transcytosi
would
engag
fcrn
mediat
unidirect
transloc
immun
complex
subepitheli
space
extern
secret
studi
report
env
igg
antibodi
inhibit
transcytosi
one
studi
found
polyclon
antihiv
env
igg
inhibit
transcytosi
cellfre
viru
cell
wherea
none
mab
fact
mab
might
increas
transcytosi
although
knowledg
none
studi
carri
acid
condit
character
femal
genit
tract
secret
result
suggest
fcrn
might
facilit
infect
host
without
preexist
antibodi
nonneutr
igg
respons
prior
infect
would
result
secondari
infect
vaccin
howev
fcrn
could
also
play
benefici
role
prevent
infect
exposur
fcrn
mediat
bidirect
transcytosi
igg
immun
individu
could
provid
conduit
antibodi
neutral
viru
shown
herp
simplex
viru
type
addit
igg
immun
complex
prime
cell
fcrndepend
manner
fcrn
target
may
use
mucos
immun
strategi
summari
demonstr
fcrn
mediat
enhanc
transcytosi
presenc
low
ph
antibodi
also
shown
fcrn
present
epitheli
cell
area
genit
tract
potenti
expos
sexual
intercours
find
point
toward
novel
mechan
sexual
transmiss
may
facilit
research
approv
institut
review
board
univers
california
irvin
boston
univers
univers
alabama
birmingham
subject
specimen
collect
studi
purpos
provid
written
inform
consent
antibodi
hivig
igg
deriv
pool
plasma
hivinfect
individu
monoclon
antibodi
mab
obtain
nih
aid
reagent
program
ivig
gamunex
taleri
biotherapeut
commerci
acquir
mab
control
mab
provid
denni
burton
brian
moldt
control
mab
gift
wayn
marasco
danafarb
cancer
institut
control
mab
gener
purif
dimer
monomer
version
describ
elsewher
briefli
igg
constant
region
igg
replac
constant
region
express
cell
human
j
chain
purifi
protein
l
affin
matrix
pierc
miga
diga
isol
size
exclus
chromatographi
human
mab
env
provid
david
corti
antonio
lanzavecchia
variant
construct
follow
human
j
chain
precursor
access
number
allel
access
number
allel
access
number
constant
region
nucleotid
sequenc
codon
optim
synthes
genscript
constant
region
clone
mammalian
express
vector
use
subclon
vh
region
vh
vl
chain
codon
optim
synthes
genscript
clone
iglambda
express
vector
mab
produc
transient
transfect
freestyl
cell
polyethylenimin
express
plasmid
encod
correspond
heavi
light
chain
case
j
chain
express
plasmid
includ
supernat
fluid
transfect
cell
collect
day
cultur
affin
purifi
peptid
protein
chromatographi
purifi
ab
quantifi
elisa
use
ab
southern
biotech
puriti
polymer
state
confirm
nativepag
analysi
gel
filtrat
chromatographi
presenc
associ
jchain
confirm
western
blot
nativ
sdspage
gel
sera
zambian
clade
cinfect
subject
obtain
zdenek
hel
univers
alabama
birmingham
pool
igg
isol
use
pierc
melon
gel
igg
spin
purif
kit
thermo
scientif
accord
manufactur
instruct
envspecif
igg
determin
cvl
semin
fluid
see
total
igg
sera
five
uninfect
individu
pool
process
igg
isol
manner
fc
mutant
design
enhanc
reduc
mab
bind
fcrn
construct
follow
briefli
variabl
region
pcramplifi
clone
pklc
vector
amino
acid
substitut
introduc
quikchang
sitedirect
mutagenesi
stratagen
la
jolla
ca
construct
verifi
sequenc
analysi
transient
express
freestyl
cell
invitrogen
carlsbad
ca
purifi
protein
affin
chromatographi
ge
healthcar
unit
kingdom
antibodi
test
neutral
activ
indic
strain
use
tzmbl
cell
halfarea
plate
corn
coat
mgml
ngwell
goat
antihuman
fc
antibodi
incub
night
plate
wash
pb
block
nonfat
dri
milk
hour
room
temperatur
rt
wash
captur
antibodi
ad
mgml
ngwell
plate
incub
addit
hour
rt
next
viru
ad
wash
plate
ng
incub
hour
unbound
viru
remov
wash
pb
subsequ
tzmbl
cellswel
ad
presenc
mgml
deae
dextran
incub
hour
cell
wash
lyse
develop
luciferas
assay
reagent
accord
manufactur
instruct
promega
luminesc
rel
light
unit
measur
use
synergi
micropl
luminomet
biotek
measur
bind
antibodi
either
viru
directli
coat
elisapl
well
solubil
env
direct
viru
bind
assay
plate
coat
jrfl
ng
hour
wash
pb
block
nonfat
dri
milk
pb
hour
plate
wash
antibodi
ad
serial
dilut
incub
hour
detector
antibodi
hors
radish
peroxidaselabel
goat
antihuman
fc
ad
wash
plate
incub
min
final
plate
wash
develop
tmb
solut
life
technolog
read
nm
use
plate
reader
biotek
solubl
env
bind
assay
perform
previous
describ
modif
briefli
well
coat
ng
env
specif
aalto
bioscienc
wash
block
nonfat
dri
milk
serial
dilut
detergentsolubil
jrfl
start
ng
ad
incub
hour
plate
incub
constant
concentr
antibodi
mgml
hour
follow
detect
develop
step
describ
five
clade
c
transmittedfound
env
pseudotyp
strain
construct
describ
briefli
revvpuenv
cassett
transmit
founder
strain
clone
pcdna
topoh
express
vector
pseudotyp
virus
produc
cotransfect
cell
pcdna
revvpuenv
fugen
roch
cervicovagin
lavag
cvl
semin
fluid
collect
patient
healthi
volunt
univers
alabama
birmingham
subject
gave
written
consent
accord
irbapprov
protocol
cvl
collect
one
yearold
uninfect
women
three
infect
women
age
year
lymphocyt
count
plasma
viral
load
copiesml
copiesml
copiesml
respect
viral
load
measur
cvl
fluid
specimen
two
women
lower
plasma
viral
load
receiv
antiretrovir
therapi
briefli
cvl
fluid
obtain
flush
cervix
vagina
ml
steril
salin
wash
collect
tube
proteas
inhibitor
semin
fluid
obtain
two
uninfect
men
age
year
three
infect
men
age
year
masturb
count
infect
men
mm
plasma
viral
load
copiesml
copiesml
copiesml
respect
one
subject
viral
load
copiesml
receiv
antiretrovir
therapi
semin
fluid
assay
rna
pcr
none
detect
cervicovagin
semin
fluid
centrifug
supernat
fluid
aliquot
frozen
assay
total
igg
determin
elisa
igg
isol
accomplish
incub
sampl
protein
gsepharos
ge
healthcar
bioscienc
corp
follow
elut
bound
igg
accord
manufactur
instruct
igg
prepar
concentr
dialyz
dpb
use
amicon
centrifug
filter
unit
millipor
corp
igg
prepar
two
uninfect
men
pool
obtain
suffici
quantiti
experi
igg
prepar
test
individu
envspecif
igg
bind
level
semin
cvl
fluid
quantifi
elisa
detergentsolubil
env
captur
polyclon
sheep
antibodi
aalto
bio
reagent
ltd
sampl
igg
mab
standard
serial
dilut
ad
well
wash
detect
antihuman
igg
gamma
hrp
sigmaaldrich
antibodi
plate
subsequ
develop
stop
read
od
nm
concentr
envspecif
igg
semin
cvl
igg
sampl
calcul
use
mab
standard
report
percent
total
igg
sampl
antienv
igg
rang
total
igg
semin
fluid
specimen
total
igg
cvl
fluid
specimen
figur
transcytosi
assay
conduct
use
reproduct
tractderiv
human
endometri
carcinoma
intestin
tractderiv
human
colon
carcinoma
cell
cell
monolay
creat
mm
polyethylen
terephthal
membran
hang
transwel
insert
millipor
cell
viabil
time
plate
electr
resist
across
membran
rang
mohmscm
start
transcytosi
assay
confirm
monolay
integr
resist
remeasur
transcytosi
assay
well
rang
mohm
cm
alon
antibodi
ad
monolay
media
buffer
ph
hour
fluid
lower
chamber
subnat
fluid
maintain
ph
collect
use
measur
viral
rna
copi
number
infect
absenc
cell
monolay
viru
inoculum
present
lower
chamber
well
hour
fcrn
knockdown
cell
cell
transduc
fcrn
shrna
lentivir
particl
santa
cruz
biotechnolog
inc
follow
manufactur
protocol
cell
select
medium
contain
mgml
puromycin
dihydrochlorid
sigmaaldrich
inc
fcrn
express
verifi
flow
cytometri
use
rabbit
polyclon
antifcrn
antibodi
santa
cruz
biotechnolog
inc
normal
rabbit
igg
neg
control
fitcgoat
antirabbit
igg
f
secondari
antibodi
jackson
immunoresearch
laboratori
inc
figur
cytofixcytoperm
plu
kit
bd
bioscienc
use
fix
permeabil
stain
cell
knockdown
fcrn
also
confirm
western
blot
use
rabbit
antifcrn
antibodi
novu
biolog
figur
wildtyp
knockdown
cell
similar
viabil
neither
wildtyp
knockdown
cell
stain
fccriia
fccriiia
shown
cell
incub
mgml
rabbit
polyclon
antifcrn
igg
santa
cruz
biotechnolog
inc
normal
rabbit
polyclon
igg
hour
ph
expos
apic
surfac
hivig
ivig
synagi
similarli
cell
incub
mm
bafilomycin
santa
cruz
biotechnolog
inc
hour
prior
antibodi
exposur
transcytosi
carri
cervic
tissu
includ
portion
endocervix
upper
vagina
ectocervix
obtain
women
age
undergo
hysterectomi
nonmalign
condit
vagin
tissu
also
obtain
women
undergo
vagin
repair
n
age
year
penil
tissu
includ
urethra
n
foreskin
n
harvest
autopsi
men
age
histori
hormon
immunosuppress
medic
tissu
process
within
minut
surgic
remov
sampl
either
embed
tissuetek
optim
cut
temperatur
compound
sakura
finetek
usa
inc
rapidli
frozen
store
frozen
section
fix
formaldehyd
process
paraffin
embed
alkalin
phosphatas
immunohistolog
techniqu
describ
previous
two
antifcrn
antibodi
use
antifcrn
antibodi
purifi
rabbit
serum
rais
domain
human
fcrn
provid
neil
simist
brandei
univers
use
frozen
section
figur
rabbit
antifcrn
antibodi
obtain
novu
biolog
use
paraffin
section
follow
citrat
buffer
ph
antigen
retriev
figur
section
block
serumfre
protein
solut
optim
dilut
primari
fcrn
antibodi
rabbit
igg
neg
control
ad
incub
hour
rt
bind
antibodi
fcrn
tissu
visual
use
alkalin
phosphatas
detect
system
stain
posit
cell
bright
red
section
counterstain
hematoxylin
coverslip
use
aqueou
mount
medium
differ
amount
transcytos
infecti
viru
condit
compar
use
kruskalw
repeatedmeasur
ancova
repeatedmeasur
ancova
percentag
transcytos
infecti
viru
logittransform
normal
evalu
use
shapirowilk
test
correl
continu
variabl
evalu
spearman
rho
twotail
pvalu
report
figur
transcytosi
ph
time
jrfl
hivig
ivig
antibodi
appli
apic
surfac
cell
ph
indic
time
subnat
fluid
ph
collect
transcytosi
quantifi
rtpcr
